FDA approves Eprex for anemia related to AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D001688:Biological Products / Q000627:therapeutic use*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products; D011994:Recombinant Proteins; D004921:Erythropoietin